Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Into the bunker: drone attacks bring war home to Russia
    • US debt ceiling deal heads towards first House vote after clearing initial hurdle
    • West steps up pressure on Turkey to admit Sweden into Nato
    • Pentagon accuses Chinese fighter jet of ‘aggressive’ action near US plane
    • ‘People rot from the inside out’: lethal xylazine deepens the US drug crisis
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • UK’s top private equity executives take home £2.7bn in carried interest
      • How Singapore Airlines soared while regional rival Cathay Pacific stalled
      • Prudential’s chief financial officer resigns after conduct probe
      • Goldman Sachs weighs fresh job cuts as dealmaking drought persists
      • Monzo increases bad loan provisions after buy now, pay later push
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news updates from May 31: Macron backs Nato ‘path’ for Ukraine, US jobs openings jump
      • Loan market braced for rush to Libor finish line
      • Monzo increases bad loan provisions after buy now, pay later push
      • Soda ash group aims to be ‘big fish’ in London with $7.5bn valuation target
      • Wall Street prepares to take on established crypto companies
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Game, set and almost match to Biden on the debt ceiling
      • Why DeSantis is losing Republicans to Trump
      • SVB’s collapse was one thing, Credit Suisse’s quite another
      • How the Thatcherites lost their Brexit dream and their party
      • Fixing Britain’s broken housing market
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • ‘Everyone has the right to completely log off’: what bosses think about the right to disconnect
      • Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Dyson’s new wheeze? An air purification system you wear on your head
      • Trump or not, US meltdown could be inevitable
      • Bruce Springsteen battles mortality in three-hour Edinburgh show
      • The UK’s best bakeries: the readers’ picks
      • Who makes the best butter?
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Scientific research

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 19 May, 2023
      LexAgeing Populations
      Longevity start-ups: hefty funding fails to find fount of youth Premium content

      Human life appears to have an upper limit that has yet to be extended

    • Sunday, 14 May, 2023
      Dementia
      Japan pushes for strong pledges on tackling dementia from G7 allies

      Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago

    • Thursday, 11 May, 2023
      Brexit
      UK participation in EU Horizon programme delayed over talks on costs

      Britain complains it is expected to pay too much to rejoin flagship research project

    • Thursday, 11 May, 2023
      Science
      Study reveals scale of ‘science scam’ in academic publishing

      One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way

    • Monday, 1 May, 2023
      Healthcare
      UK partnerships with life sciences groups threatened by NHS pressures

      Hurdles facing drug trials point to challenges for Britain’s drive for innovation

    • Wednesday, 26 April, 2023
      Medical science
      US regulators approve first human pill derived from faecal matter

      FDA gives green light to C. difficile treatment in boost for microbiome drug developers

    • Friday, 14 April, 2023
      Space exploration
      Juice spacecraft begins eight-year voyage to Jupiter after successful launch

      Complex mission will search for signs of ocean life on icy moons close to solar system’s biggest planet

    • Thursday, 13 April, 2023
      Detection tool developed to fight flood of fake academic papers

      Journals seek to tackle increased use of unauthorised ‘paper mills’ to produce research studies

    • Thursday, 13 April, 2023
      Medical science
      Adopt ‘pop-up’ model to boost clinical trials, UK review argues

      New system could be modelled on Covid-19 vaccinations to ease pressure on hospitals

    • Wednesday, 12 April, 2023
      Medical science
      Genetic profile of lung cancer can predict disease’s next move

      UK scientists carry out most comprehensive study so far of tumour evolution and its implications for treatment

    • Thursday, 6 April, 2023
      UK politics & policy
      UK sets out £14.6bn science scheme as back-up to EU’s Horizon

      Scientific leaders cautiously welcome Pioneer, which would run for 7 years, but urge re-entry to bloc’s €96bn programme

    • Tuesday, 4 April, 2023
      Illumina Inc
      Illumina battle with regulators threatens cancer breakthrough, warn Grail alumni

      Founding directors say political wrangling causing delays to potentially life-saving blood test

    • Wednesday, 29 March, 2023
      Brexit
      UK re-entry into EU Horizon programme threatened by cash dispute

      Britain seeks to reduce contributions to €95bn research network seen as vital by country’s scientists

    • Wednesday, 29 March, 2023
      Science
      UK’s 220-year-old Royal Institution seeks to reinstate itself as ‘home for science’

      London-based organisation hosted the announcement of many of the 19th century’s most important scientific discoveries

    • Tuesday, 28 March, 2023
      The Big Read
      China’s fake science industry: how ‘paper mills’ threaten progress

      The country has become a prolific producer of academic research but fraudulent studies risk serious real-world consequences

    • Monday, 20 March, 2023
      Climate change
      Global warming set to reach 1.5C in the near-term, UN reports

      Risks of warming and irreversible changes to the planet greater than thought in previous assessment in 2014

    • Wednesday, 15 March, 2023
      UK Budget
      Computing and life sciences to benefit from UK financial and regulatory measures

      Chancellor Jeremy Hunt vows to make Britain the ‘best place in Europe’ for tech companies to invest

    • Wednesday, 15 March, 2023
      Medical science
      High sucralose doses suppress immune system, research on mice shows

      Unexpected finding suggests popular sweetener could treat autoimmune conditions such as arthritis and diabetes

    • Wednesday, 15 March, 2023
      Anjana Ahuja
      World-leading? Britain’s science sector has some way to go

      The country’s reputation is inflated by historic successes and relies on successful outliers

    • Wednesday, 8 March, 2023
      Genomics
      Cost of gene treatments for once incurable diseases too high, scientists warn

      Therapies based on editing of human genomes predicted to have a price tag of $2mn per patient

    • Friday, 3 March, 2023
      Plastic pollution
      Plastic ingestion by humans and animals altering cells, scientists say

      Study identifies new stomach disease in seabirds caused by microplastics

    • Friday, 3 March, 2023
      UK politics & policy
      Sunak holds back on rejoining Horizon after Brexit breakthrough

      Prime minister said to be ‘sceptical’ about value of research programme and cost of UK participation

    • Thursday, 2 March, 2023
      Climate change
      Wildfires in boreal forests release record levels of carbon, satellite study shows

      Burning trees across Eurasia and North America emitted 1.76bn tonnes of CO₂ in 2021

    • Monday, 27 February, 2023
      UK scientists hail prospect of Horizon re-entry after Brexit deal

      Researchers welcome EU Commission president’s pledge to begin work on accession accord

    • Thursday, 16 February, 2023
      ExplainerScience
      Spy balloons, sky clutter and UFOs: what flies in the ‘forgotten space’?

      Objects in the upper stratosphere are used for science, surveillance and communications

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Transforming Approaches to Triple-Negative Breast Cancer
    Raising awareness, innovating treatments and improving patient support
    Thursday, 8th JuneOnline
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In